XML 21 R11.htm IDEA: XBRL DOCUMENT v3.23.3
Revenues
 9 Months Ended
Sep. 30, 2023
Revenue from Contract with Customer [Abstract]  
Revenues
Note 3. Revenues
Revenues are recognized under guidance within ASC 606, Revenue from Contracts with Customers. The following table presents our disaggregated revenue for the periods presented (in thousands):
Three Months Ended
September 30,		Nine Months Ended
September 30,
2023202220232022
JAKAFI revenues, net$636,252 $619,595 $1,898,605 $1,761,732 
OPZELURA revenues, net91,836 38,140 228,621 67,454 
ICLUSIG revenues, net27,721 25,929 84,493 78,222 
PEMAZYRE revenues, net18,942 23,414 62,989 60,429 
MINJUVI revenues, net8,348 5,932 28,063 14,845 
ZYNYZ revenues, net98 — 668 — 
Total product revenues, net783,197 713,010 2,303,439 1,982,682 
JAKAVI product royalty revenues96,551 85,808 263,691 240,386 
OLUMIANT product royalty revenues29,615 20,371 95,779 98,689 
TABRECTA product royalty revenues4,139 4,114 13,115 11,178 
PEMAZYRE product royalty revenues523 — 1,284 — 
Total product royalty revenues130,828 110,293 373,869 350,253 
Milestone and contract revenues5,000 — 5,000 135,000 
Total revenues$919,025 $823,303 $2,682,308 $2,467,935 
For further information on our revenue-generating contracts, refer to Note 7.